Dr Adam T. Perzynski joins Ethics Talk to discuss his article, coauthored with Dr Kurt C. Stange: “How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters?”
Michael Toppe, DMSc, PA-C and Lushiku Nkombua, MD, MMed
American physician assistant students trained in South Africa to study an example of a reverse innovation practice that could be incorporated in the US.
AMA J Ethics. 2023;25(5):E332-337. doi:
10.1001/amajethics.2023.332.
Alysse Gail Wurcel, MD, MS, Jacinda C. Abdul-Mutakabbir, PharmD, MPH, Shira Doron, MD, Christina Yen, MD, and Justin Berk, MD, MPH, MBA
Antimicrobial resistance is a global threat that inequitably affects minoritized populations, including Black, Latinx, and Indigenous people, especially in carceral settings.
AMA J Ethics. 2024;26(5):E399-407. doi:
10.1001/amajethics.2024.399.
Drs Lynne Fehrenbacher and Leah Leonard-Kandarapally join Ethics Talk to discuss key roles of infectious disease pharmacists in antimicrobial stewardship.
Dr Kelly Gillespie joins Ethics Talk to discuss her article, coauthored with Dr Taleed El-Sabawi: “When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?”